News
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
The results expose a striking prevalence of high-risk sexual behaviours. Over one-third of participants (34.0%) disclosed ...
A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...
Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...
2dOpinion
LGBTQ Nation on MSNHIV Awareness still belongs at the heart of Pride MonthToday, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...
People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...
In the mid-nineties, a friend of mine told me that he lost 30 friends and acquaintances to HIV/AIDS in just one week. It was a miracle that he was still alive. Although cases have decreased ...
Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results